Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session



  • Ocean Biomedical, Inc. OCEA shares climbed 62.3% to $7.61 after the company shared detailed research data on anti-tumor pathway discoveries and their potential for treatment of non-small cell lung cancer, metastatic melanoma, and glioblastoma by Scientific Co-founder, Dr. Jack A. Elias, MD.
  • Toro Corp. TORO shares climbed 53.2% to $5.90.
  • Unicycive Therapeutics, Inc. UNCY gained 36% to $2.21. EF Hutton initiated coverage on Unicycive Therapeutics with a Buy rating and announced a price target of $5.
  • Holley Inc. HLLY surged 32% to $2.6099 following Q4 results.
  • Intuitive Machines, Inc. LUNR rose 30.3% to $13.37
  • Solo Brands, Inc. DTC gained 28.1% to $5.15 after the company announced better-than-expected Q4 results.
  • Biophytis S.A. BPTS rose 27.9% to $0.6460 after the company said it will present results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 at the European Respiratory Society 2023 21st Lung Science Conference taking place in Estoril, Portuga.
  • Neoleukin Therapeutics, Inc. NLTX shares rose 26.3% to $0.6703. Neoleukin Therapeutics engaged SVB Securities to assist in reviewing strategic alternatives. The company also approved a further corporate restructuring to preserve cash, including reducing its workforce by approximately 70%.
  • Asana, Inc. ASAN rose 26.3% to $22.48 as the company reported better-than-expected Q4 results and issued strong forecast for the current quarter.
  • Build-A-Bear Workshop, Inc. BBW gained 22.5% to $25.23 after the company reported fourth-quarter FY22 sales growth of 11.6% year-on-year to $145.11 million, beating the consensus of $137.54 million.
  • KLX Energy Services Holdings, Inc. KLXE jumped 21.4% to $16.48 following Q4 results.
  • BYND Cannasoft Enterprises Inc. BCAN rose 19.8% to $4.36 after gaining over 9% on Wednesday.
  • Avenue Therapeutics, Inc. ATXI shares rose 19.4% to $1.2425 after the company issued regulatory update on IV Tramadol and other corporate updates.
  • Kaival Brands Innovations Group, Inc. KAVL gained 18.6% to $0.7899. Kaival Brands signed an agreement with a prominent national broker, increasing potential distribution by upwards of 40,000 retail stores.
  • Townsquare Media, Inc. TSQ gained 18% to $8.56 following strong quarterly results.
  • Paysafe Limited PSFE jumped 15.7% to $23.49. Paysafe reported a fourth-quarter FY22 revenue growth of 3% year-on-year to $383.6 million, beating the consensus of $376.1 million.
  • Stabilis Solutions, Inc. SLNG gained 15.6% to $3.5605 after posting a profit for the fourth quarter.
  • Duluth Holdings Inc. DLTH jumped 14.7% to $7.09 following upbeat quarterly earnings.
  • Finch Therapeutics Group, Inc. FNCH gained 14.6% to $0.4599.
  • FuelCell Energy, Inc. FCEL jumped 13.9% to $3.76 after the company reported better-than-expected Q1 EPS and sales results.
  • Versus Systems Inc. VS shares rose 13.4% to $0.6799. Versus Systems, last month, announced a $2.25 million registered direct offering.
  • Assertio Holdings, Inc. ASRT gained 13% to $6.74 following strong quarterly sales.
  • Miller Industries, Inc. MLR jumped 11.8% to $30.40 after reporting a rise in Q4 earnings.
  • Troika Media Group, Inc. TRKA rose 11.4% to $0.3820 after dipping around 39% on Wednesday. Troika Media recently reported revenue of $187.91 million for the six months ended FY22, up from $15.34 million a year ago.
  • Sovos Brands, Inc. SOVO gained 11.4% to $14.66 after the company reported better-than-expected Q4 results and issued strong FY23 guidance.
  • Docebo Inc. DCBO gained 10.2% to $39.41 following upbeat quarterly earnings.
  • Nuvei Corporation NVEI jumped 8.4% to $39.47. Credit Suisse upgraded Nuvei from Neutral to Outperform and raised the price target from $37 to $45.


  • InVivo Therapeutics Holdings Corp. NVIV shares dipped 48.2% to $1.0873 after the company announced topline data from its INSPIRE 2.0 study in acute spinal cord injury, in which the primary endpoint was not met.
  • SVB Financial Group SIVB fell 37.4% to $167.36 after the parent of Silicon Valley Bank announced proposed offerings of common stock and convertible preferred stock.
  • Silvergate Capital Corporation SI shares fell 28.7% to $3.60 after the company announced it will wind down operations and voluntarily liquidate Silvergate Bank.
  • Akebia Therapeutics, Inc. AKBA dipped 23% to $0.7931 following Q4 results.
  • Titan Medical Inc. TMDI fell 22.2% to $0.1479 after the company reported decision of Nasdaq Hearings Panel to delist common shares.
  • Stagwell Inc. STGW dropped 20.9% to $6.95 after the company announced the launch of a 16 million share secondary offering of common stock.
  • Predictive Oncology Inc. POAI fell 18% to $0.3361.
  • Fulcrum Therapeutics, Inc. FULC fell 17.3% to $5.18. Fulcrum Therapeutics posted a Q4 loss of $0.50 per share.
  • PacWest Bancorp PACW dipped 16.9% to $22.17.
  • VSE Corporation VSEC fell 16.7% to $47.17 following weak quarterly results.
  • Elys Game Technology, Corp. ELYS tumbled 16.7% to $0.5241.
  • John Wiley & Sons, Inc. WLY fell 15.7% to $36.65 after posting downbeat quarterly results.
  • Arhaus, Inc. ARHS dipped 14.7% to $10.92 following Q4 results.
  • Kronos Worldwide, Inc. KRO dropped 14.6% to $9.32 following Q4 results.
  • Novo Integrated Sciences, Inc. NVOS shares fell 14.5% to $0.1650 after dropping 5% on Wednesday.
  • Helen of Troy Limited HELE dropped 10.3% to $102.63. Helen of Troy announced resignation of CFO Matt Osberg.
  • Exela Technologies, Inc. XELA fell 9.3% to $0.0624 after gaining 12% on Wednesday.
  • JD.com, Inc. JD fell 8.8% to $42.87 after the company Q4 financial results.
  • Borqs Technologies, Inc. BRQS fell 8.5% to $0.2633. Borqs Technologies shares gained 17% on Wednesday after the company announced a contract to develop and manufacture an Android 5G rugged waterproof handheld device.
  • MongoDB, Inc. MDB shares dropped 7.1% to $212.89 after the company issued weak revenue guidance.
  • Etsy, Inc. ETSY fell 4% to $108.62 after Jefferies downgraded the stock from Buy to Underperform and lowered the price target from $150 to $85.

Now Read This: Top 5 Consumer Staples Stocks That Could Lead To Your Biggest Gains In March

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!